| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 05/27/2004 | WO2004043339A2 Substituted cycloalkyl p1' hepatitis c virus inhibitors |
| 05/27/2004 | WO2003089455A3 Low-cost production of peptides |
| 05/27/2004 | WO2003031623A9 Cocoa flavour precursor peptides |
| 05/27/2004 | US20040102609 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/27/2004 | US20040102478 Alzheimer's and Parkinson's disease; antiinflamamtory agents; antiallergens; vision defects |
| 05/27/2004 | US20040102448 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 05/27/2004 | US20040102384 Pyrrolidine derivatives and their use as chymase inhibitor |
| 05/27/2004 | US20040102370 Peptides that stimulate cell survival and axon regeneration |
| 05/27/2004 | US20040101864 Chemical process |
| 05/27/2004 | DE10252719A1 New tubulysin analogs, useful for treating tumor or cancer diseases, immunologically induced or autoimmune diseases, inflammatory diseases or rheumatoid arthritis or for surface modification of implants |
| 05/27/2004 | CA2504768A1 Compounds and methods for modulating functions of classical cadherins |
| 05/26/2004 | EP1422236A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 05/26/2004 | EP1421204A2 Iap binding peptides and assays for identifying compounds that bind iap |
| 05/26/2004 | EP1421198A2 Cell-based high-throughput screening methods |
| 05/26/2004 | EP1421107A1 Peptides having antiangiogenic activity |
| 05/26/2004 | EP1421105A1 Anti-cancer cyclopenta[g]quinazoline compounds |
| 05/26/2004 | EP1420681A2 Peptide-based multimeric targeted contrast agents |
| 05/26/2004 | EP1159296B1 METHOD FOR PRODUCING CYCLO-(Asp-DPhe-NMeVal-Arg-Gly) |
| 05/26/2004 | CN1500145A Method for sectetion and prodn. of protein |
| 05/26/2004 | CN1500085A Lipid lowering biphenylcarboxamides |
| 05/25/2004 | US6740760 Such as 1-((s)-3-mercapto-2-methyl-propionyl)-(r)-pyrrol-idine-2-carboxylic acid for treating diseases associated with amyloidosis (alzheimer's disease, diabetes, and familial amyloid polyneuropathy) |
| 05/25/2004 | US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/25/2004 | US6740647 Amidines and hydroxyamidine derivatives |
| 05/21/2004 | WO2004041840A2 Peptide-bound chromogens used for determining enzymatic activities |
| 05/21/2004 | WO2004041297A2 Modified cytokines for use in cancer therapy |
| 05/20/2004 | US20040097735 Mercaptan containing diagnostic agents for imaging malignant melanoma and distant metastases and rhenium (186Re, 188Re) therapeutic complexes for treating the same |
| 05/20/2004 | US20040097730 Amide containing a pyridinone or pyrazinone compound as serine protease enzyme inhibitors |
| 05/20/2004 | US20040097702 Thiopeptide compounds |
| 05/20/2004 | US20040097496 Novel thiazine derivatives |
| 05/20/2004 | US20040097425 Peptide compounds |
| 05/20/2004 | US20040097422 Methods of use for tripeptidyl peptidase II inhibitors as anticancer agents |
| 05/20/2004 | US20040097421 Melphalan derivatives and their use as cancer chemotherapeutic drugs |
| 05/20/2004 | US20040097420 Proteasome regulation of NF-kB activity |
| 05/20/2004 | US20040097416 Analgesics; neuropathic pain; bipolar disorders |
| 05/20/2004 | US20040097413 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 05/20/2004 | US20040097403 Linkable sialyl lewis x analogs |
| 05/19/2004 | EP1420030A2 Method for synthesis of (2S,3aS,7aS)-1-[(S)-alanyl]-octahydro-1H-indole-2-carboxylic acid derivatives and use in the synthesis of perindopril |
| 05/19/2004 | EP1420029A2 Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 05/19/2004 | EP1420028A2 Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 05/19/2004 | EP1420010A1 Amphoteric lipid compound and use thereof |
| 05/19/2004 | EP1419172A2 Bi-directional synthesis of oligoguanidine transport agents |
| 05/19/2004 | EP1000051B1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/19/2004 | EP0717736B1 Phosphorus derivatives to treat aids |
| 05/19/2004 | DE10251894A1 New peptide-containing benzophenoxazine or napthoquinone derivatives, useful as chromogenic substrates for enzymes, e.g. for diagnosis, monitoring therapy and detecting pyrogens |
| 05/19/2004 | DE10251747A1 Gentechnisch veränderte Penicillinamidase und Verfahren zu ihrer Herstellung Genetically modified penicillin and process for their preparation |
| 05/19/2004 | CN1498224A Novel peptides as NS3-serine protease inhibitors of hepatitiscvirus |
| 05/19/2004 | CN1498111A Compounds comprising disulfide-containing peptides and nitrogenous bases, and medical uses thereof |
| 05/19/2004 | CN1150318C Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies |
| 05/19/2004 | CN1150205C 3-mercaptoacetylamino-1,5-subsd.2-oxo-axepon derivatives useful as inhibitor of metrix metalloproteinaes |
| 05/19/2004 | CN1150028C Tri-, tetra-, penta- and polypeptides and their therapeuitc use as antidepressant agent |
| 05/18/2004 | US6737420 Compounds to treat Alzheimer's disease |
| 05/18/2004 | US6737410 Smooth muscle antiproliferation agents; such as 1-((2-(4-benzyloxy-phenyl)-1-phenethylcarbamoyl-ethyl)-methyl-carbamoyl)-2 -(1h-imidazol-4-yl)-ethyl)-carbamic acid benzyl ester |
| 05/18/2004 | US6737409 For cancer therapy |
| 05/18/2004 | US6737247 Detecting enzymatic activity in sample; obtain substrate, incubate with target tissue, detect amplified relaxivity of sample, evaluate enzymatic activity sample |
| 05/13/2004 | WO2004039833A1 Composition for the treatment of infection by flaviviridae viruses |
| 05/13/2004 | US20040092736 Collections of compounds |
| 05/13/2004 | US20040092582 Antiinflammatory agents; respiratory system disorders; antiarthritic agents; autoimmune diseases; antidiabetic agents |
| 05/13/2004 | US20040091955 Process and compositions for peptide, protein and peptidomimetic synthesis |
| 05/13/2004 | US20040091426 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 05/13/2004 | CA2498642A1 Composition for the treatment of infection by flaviviridae viruses |
| 05/12/2004 | EP1418235A2 Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 05/12/2004 | EP1418230A2 Genetically modified penicillin amidase and methods of producing it |
| 05/12/2004 | EP1417220A2 Irreversible cysteine protease inhibitors of legumain |
| 05/12/2004 | EP1417219A2 Libraries of conformationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same |
| 05/12/2004 | EP1417190A1 Substituted piperazines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1417055A2 Use of copper chelators to inhibit the inactivation of protein c |
| 05/12/2004 | EP1416934A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 05/12/2004 | EP1416933A1 Substituted piperidines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1226267B1 Process for producing a product containing antihypertensive tripeptides |
| 05/12/2004 | EP1084409B1 Method and device for electrochemical immunoassay of multiple analytes |
| 05/12/2004 | EP1066316B1 Cinnamic acid derivatives having cell adhesion modulating activity |
| 05/12/2004 | EP0927192B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 05/12/2004 | CN1496368A Immunopotentiators |
| 05/12/2004 | CN1495186A Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate |
| 05/12/2004 | CN1149223C Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/12/2004 | CN1149210C Thrombin inhibitors |
| 05/06/2004 | WO2004037855A1 Macrocyclic peptides active against the hepatitis c virus |
| 05/06/2004 | WO2004037854A1 Prion protein-binding peptide sequences |
| 05/06/2004 | WO2004037169A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/06/2004 | WO2003097664A3 Non-covalent inhibitors of cysteine proteases with atripeptide backbone |
| 05/06/2004 | WO2003089922A8 Method for detecting ligands and targets in a mixture |
| 05/06/2004 | WO2003086470A3 Smac-peptides as therapeutics against cancer and autoimmune diseases |
| 05/06/2004 | WO2003051837A8 Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr) |
| 05/06/2004 | WO2002038108A3 Methods of treating disorders related to apoe |
| 05/06/2004 | US20040087648 Benzothiepine 1, 1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
| 05/06/2004 | US20040087647 Enzyme inhibitors; prevent thrombosis; anticoagulants |
| 05/06/2004 | US20040087511 Peptide derivatives |
| 05/06/2004 | US20040087508 Users for amino acid anticonvulsants |
| 05/06/2004 | US20040087504 Novel peptide sy |
| 05/06/2004 | US20040087497 CD10-activated prodrug compounds |
| 05/06/2004 | US20040086965 Casein peptide fragments with growth-influencing activity on cell cultures |
| 05/06/2004 | US20040086943 Coupling agent containing secordary amide groups |
| 05/06/2004 | EP1415992A1 Diamine derivatives |
| 05/06/2004 | EP1415006A2 Assay for identifying inhibitors of hiv rt dimerization |
| 05/06/2004 | EP1414849A2 Immune-modulating peptide |
| 05/06/2004 | EP1414792A1 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates |
| 05/06/2004 | EP0821696B1 Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use |
| 05/05/2004 | CN1148360C Intermediate for preparing cascade polymeric ligand usable as contrast medium |
| 05/04/2004 | US6730686 Methods for inhibiting oxidative modification of proteins |
| 05/04/2004 | US6730669 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |